- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Cypress Bioscience Inc. (CYPB)
by latest | most commented
-
Cypress Bioscience: Investing in Pain
-
FDA, Clinical Trial Calendar Updates: Actelion, Merck Discontinue Partnership
-
Bullish Thesis for Biotech Remains Intact
-
Looking for the Biotech Breakout
-
Thursday Options Update: BAC, C, AAPL, CYPB & SQNM
-
Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys
-
Stocks Affected by FDA Calendar of Expected Decision Dates
-
20 Emerging Healthcare Stocks to Watch in '09
-
9 Possible Pharma Deals for 2009
-
4 Drug Stocks Trading Above Moving Averages
-
3 Top and Bottom Market Sectors for This Week
-
Two Calculated Risks Possibly Worth Taking
-
Five Healthcare Stocks Positioned for a Happy New Year
-
Updated FDA Calendar: Cypress Bioscience Looks Like a Buy
-
Cytori Therapeutics and Cypress Bio: Two Buys Based on Positive Trial Results
-
AMAG, Caraco and More: Near-Term Catalysts, Courtesy FDA
-
Healthcare Stock Opportunities In a Down Market
-
Hedge Fund Tracking: Lee Ainslie's Maverick Capital, Q3 2008
-
Backlog of Decisions Is Building at the FDA
-
60 Defensive Growth Stocks
-
Six Healthcare Stocks at Sale Prices
-
FDA Action Before Year End
-
Potential Short Trades on Pending FDA Decisions
-
Cypress Bioscience Could Be a Buy Given Upcoming FDA Decision
-
Pharmaceuticals: Near Term Movers Based On FDA Decision Dates
-
FDA Fall Decision Calendar Features Some Likely Near-Term Movers
-
Is Cypress Bioscience Poised to Move Ahead?
-
Cypress Bioscience: About To Reverse Course?
-
Monday Options Outlook: XME, EWZ, GDX, MVL, CYPB, MOT, BID
-
Cypress Bioscience Awaits Two Key Catalysts
-
Loeb's Third Point Issues Latest 13F: Summary of Holdings
-
Rob Black's Healthcare Market Roundup